Acceptance of available traditional vaccine supply with reduced shelf-life - Interim guidance.

This interim guidance is intended to guide Member States in making decisions and developing appropriate strategies to accept and manage traditional vaccines (herewith referred to as “vaccines”) with reduced shelf-life. COVID-19 vaccines are currently not within the scope of this guidance.